Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sticherling

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
The British Journal of Dermatology|June 6, 2017
Secukinumab is superior to fumaric acid esters in treating patients with moderate-to-severe plaque psoriasis who are naive to systemic treatments: results from the randomized controlled PRIME trialM Sticherling, U Mrowietz, M Augustin, et al.
The Journal of Investigative Dermatology|October 1, 1995
Detection of the chemokine RANTES in cytokine-stimulated human dermal fibroblastsM Sticherling, M Küpper, F Koltrowitz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1990
Detection of neutrophil-activating peptide NAP/IL-8 and NAP/IL-8 mRNA in human recombinant IL-1 alpha- and human recombinant tumor necrosis factor-alpha-stimulated human dermal fibroblasts. An immunocytochemical and fluorescent in situ hybridization studyV Mielke, J G Bauman, M Sticherling, et al.
The British Journal of Dermatology|November 10, 2019
Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active-comparator-controlled phase IIIb trial (POLARIS)D Thaçi, A Pinter, M Sebastian, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 12, 2020
Bone microstructure and volumetric bone mineral density in patients with hyperuricemia with and without psoriasisD Simon, J Haschka, C Muschitz, et al.
The British Journal of Dermatology|May 12, 2017
An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsoneM Sticherling, A Franke, E Aberer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 18, 2023
Effectiveness, safety and quality-of-life effects of guselkumab and ustekinumab in patients with psoriasis: Week 104 results from the non-interventional, prospective, German multicentre PERSIST studyS Gerdes, M Hoffmann, K Asadullah, et al.
The American Review of Respiratory Disease|August 1, 1992
Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortalityE J Miller, A B Cohen, S Nagao, et al.
Zeitschrift Fur Rheumatologie|March 26, 2015
[Common German language nomenclature for systemic sclerosis]M Aringer, U Müller-Ladner, H Burkhardt, et al.
The British Journal of Dermatology|April 3, 2018
Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky scoreM M Holtsche, S Goletz, N van Beek, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
The British Journal of Dermatology|June 6, 2017
Secukinumab is superior to fumaric acid esters in treating patients with moderate-to-severe plaque psoriasis who are naive to systemic treatments: results from the randomized controlled PRIME trialM Sticherling, U Mrowietz, M Augustin, et al.
The Journal of Investigative Dermatology|October 1, 1995
Detection of the chemokine RANTES in cytokine-stimulated human dermal fibroblastsM Sticherling, M Küpper, F Koltrowitz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1990
Detection of neutrophil-activating peptide NAP/IL-8 and NAP/IL-8 mRNA in human recombinant IL-1 alpha- and human recombinant tumor necrosis factor-alpha-stimulated human dermal fibroblasts. An immunocytochemical and fluorescent in situ hybridization studyV Mielke, J G Bauman, M Sticherling, et al.
The British Journal of Dermatology|November 10, 2019
Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active-comparator-controlled phase IIIb trial (POLARIS)D Thaçi, A Pinter, M Sebastian, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 12, 2020
Bone microstructure and volumetric bone mineral density in patients with hyperuricemia with and without psoriasisD Simon, J Haschka, C Muschitz, et al.
The British Journal of Dermatology|May 12, 2017
An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsoneM Sticherling, A Franke, E Aberer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 18, 2023
Effectiveness, safety and quality-of-life effects of guselkumab and ustekinumab in patients with psoriasis: Week 104 results from the non-interventional, prospective, German multicentre PERSIST studyS Gerdes, M Hoffmann, K Asadullah, et al.
The American Review of Respiratory Disease|August 1, 1992
Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortalityE J Miller, A B Cohen, S Nagao, et al.
Zeitschrift Fur Rheumatologie|March 26, 2015
[Common German language nomenclature for systemic sclerosis]M Aringer, U Müller-Ladner, H Burkhardt, et al.
The British Journal of Dermatology|April 3, 2018
Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky scoreM M Holtsche, S Goletz, N van Beek, et al.
Pageof 9